Drug Recall Alert: Wells Pharma of Houston LLC Issues Recall for Multiple Medications
Several drugs commonly used in hospital and clinical settings are being recalled due to not meeting drug standards. The Federal Drug Administration has identified two popular drugs used for pain management and sedation that were manufactured by Wells Pharma of Houston LLC. The company issued a voluntary recall as the medications did not meet the Current Good Manufacturing Practice regulations enforced by the FDA. This has resulted in the recall of thousands of Ketamine syringes, hundreds of fentanyl syringes, and thousands of intravenous bags of the drug, along with Phenylephrine Hydrochloride Injectable Solution used to treat low blood pressure.
The failure to meet standards has prompted the recall of multiple drugs manufactured by Wells Pharma of Houston LLC. The recall is classified as a Class II recall, indicating that use or exposure to the products may cause temporary or reversible adverse health effects. The FDA emphasizes the importance of adherence to CGMP regulations to ensure the identity, strength, quality, and purity of drug products. The recall serves as a precautionary measure to prevent potential health risks associated with the affected medications.
Nexstar's WPIX attempted to contact Wells Pharma of Houston for comment on the recall, but the company was unavailable to provide a statement. The recall serves as a reminder of the importance of maintaining high manufacturing standards in the pharmaceutical industry to safeguard the health and well-being of patients. It is crucial for pharmaceutical companies to adhere to CGMP regulations to ensure the safety and efficacy of their products.